Accepted for/Published in: JMIR Formative Research
Date Submitted: Mar 15, 2022
Date Accepted: Jun 30, 2022
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Heart Rate Variability Biofeedback to treat Anxiety in Young People with Autistic Spectrum Disorder: findings from a home-based pilot study
ABSTRACT
Background:
Young people with Autistic Spectrum Disorders (ASD) frequently experience high levels of anxiety. Despite this, many clinical settings do not provide specialist ASD mental health services and demand for professional support frequently outstrips supply. Across many sectors of health, investigators have explored digital health solutions to mitigate demand and extend the reach of professional practice beyond traditional clinical settings.
Objective:
This critical appraisal and pilot feasibility study examined Heart Rate Variability Biofeedback as an approach to help people with ASD manage anxiety symptoms, outside of formal settings. The aim was to assess interventions whilst highlighting risks and benefits with this population.
Methods:
Following critical review of relevant literature, a group of 20 young people with a diagnosis of ASD (16 males: 4 females; 13-24 years) were recruited to explore the use of portable biofeedback devices, which have been reported to help regulate breathing and heart rate.
Results:
Results:
Adoption and acceptability, assessed via remote monitoring and direct interview, indicated that most participants found the devices acceptable and useful. Levels of anxiety, assessed via pre-post questionnaires, were significantly reduced in children (p = .04) and in young adults (p = .006). These initial findings are discussed within a context of the strengths and challenges for remotely delivering a biofeedback intervention for people with ASD.
Conclusions:
Heart rate variability biofeedback devices have shown promise in this pilot study. There is now a need for larger evaluation of biofeedback to determine which delivery methods achieve the greatest effect for people with ASD. Clinical Trial: NCT04955093
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.